SQ Khan

539 total citations
7 papers, 411 citations indexed

About

SQ Khan is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Rheumatology. According to data from OpenAlex, SQ Khan has authored 7 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in SQ Khan's work include Heart Failure Treatment and Management (4 papers), GDF15 and Related Biomarkers (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). SQ Khan is often cited by papers focused on Heart Failure Treatment and Management (4 papers), GDF15 and Related Biomarkers (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). SQ Khan collaborates with scholars based in United Kingdom. SQ Khan's co-authors include Leong L. Ng, P. Quinn, Joan E. Davies, Iain Squire, Matt Thompson, Gillian Cockerill, I B Squire, Onkar S. Dhillon, Kelvin Ng and Dominic F. Kelly and has published in prestigious journals such as European Heart Journal, Heart and European Journal of Heart Failure.

In The Last Decade

SQ Khan

6 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
SQ Khan United Kingdom	5	226	170	126	107	79	7	411
Antonio García‐Honrubia Spain	9	301 1.3×	84 0.5×	42 0.3×	194 1.8×	86 1.1×	19	519
Jee Hae Kim United States	5	145 0.6×	32 0.2×	76 0.6×	117 1.1×	173 2.2×	6	479
Marian Wesseling Netherlands	6	120 0.5×	40 0.2×	52 0.4×	40 0.4×	88 1.1×	11	264
Fatih Yalçın United States	9	73 0.3×	46 0.3×	189 1.5×	28 0.3×	77 1.0×	16	351
Joseph Janicki United States	9	136 0.6×	53 0.3×	47 0.4×	18 0.2×	119 1.5×	15	420
Jieyan Shen China	10	215 1.0×	24 0.1×	36 0.3×	36 0.3×	100 1.3×	26	483
Suvi Syväranta Finland	8	249 1.1×	21 0.1×	77 0.6×	28 0.3×	84 1.1×	16	411
Nwe Nwe Soe United States	8	102 0.5×	29 0.2×	86 0.7×	24 0.2×	287 3.6×	14	425
Bernadett Faragó Hungary	9	39 0.2×	72 0.4×	141 1.1×	19 0.2×	68 0.9×	16	331

Countries citing papers authored by SQ Khan

Since Specialization

Citations

This map shows the geographic impact of SQ Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SQ Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SQ Khan more than expected).

Fields of papers citing papers by SQ Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SQ Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SQ Khan. The network helps show where SQ Khan may publish in the future.

Co-authorship network of co-authors of SQ Khan

This figure shows the co-authorship network connecting the top 25 collaborators of SQ Khan. A scholar is included among the top collaborators of SQ Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SQ Khan. SQ Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hussain, Syed A., Peter Ludman, John Townend, et al.. (2021). The effect of the COVID-19 pandemic on time to angiography and outcomes in patients presenting with non-ST elevation myocardial infarction. European Heart Journal Acute Cardiovascular Care. 10(Supplement_1).

2.

Khan, SQ, Kelvin Ng, Onkar S. Dhillon, et al.. (2009). Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. European Heart Journal. 30(9). 1057–1065. 173 indexed citations

3.

Khan, SQ, I B Squire, P. Quinn, et al.. (2009). C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodelling and clinical heart failure in survivors of myocardial infarction. HighWire Press Open Archive. 95. 89–89. 1 indexed citations

4.

Khan, SQ, Kelvin Ng, Onkar S. Dhillon, et al.. (2009). Growth differentiation factor 15 as a prognostic marker in patients with acute myocardial infarction. HighWire Press Open Archive. 95. 74–74. 5 indexed citations

5.

Khan, SQ, Gillian Cockerill, Leong L. Ng, et al.. (2008). Circulating Stromelysin-1 (MMP-3): A Novel Predictor of LV Dysfunction, Remodelling and All-Cause Mortality After Acute Myocardial Infarction. European Journal of Heart Failure. 10(2). 133–139. 79 indexed citations

6.

Kelly, Dominic F., SQ Khan, Matt Thompson, et al.. (2008). Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. European Heart Journal. 29(17). 2116–2124. 108 indexed citations

7.

Khan, SQ, P. Quinn, Joan E. Davies, & Leong L. Ng. (2007). N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Heart. 94(1). 40–43. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact